124 related articles for article (PubMed ID: 8392157)
1. Modulation of morphine-induced sensitization by endogenous kappa opioid systems in the rat.
Spanagel R; Shippenberg TS
Neurosci Lett; 1993 Apr; 153(2):232-6. PubMed ID: 8392157
[TBL] [Abstract][Full Text] [Related]
2. Endogenous kappa-opioid systems in opiate withdrawal: role in aversion and accompanying changes in mesolimbic dopamine release.
Spanagel R; Almeida OF; Bartl C; Shippenberg TS
Psychopharmacology (Berl); 1994 Jun; 115(1-2):121-7. PubMed ID: 7862883
[TBL] [Abstract][Full Text] [Related]
3. Direct evidence for the involvement of the mesolimbic kappa-opioid system in the morphine-induced rewarding effect under an inflammatory pain-like state.
Narita M; Kishimoto Y; Ise Y; Yajima Y; Misawa K; Suzuki T
Neuropsychopharmacology; 2005 Jan; 30(1):111-8. PubMed ID: 15257306
[TBL] [Abstract][Full Text] [Related]
4. Evidence for roles of kappa-opioid and NMDA receptors in the mechanism of action of ibogaine.
Glick SD; Maisonneuve IM; Pearl SM
Brain Res; 1997 Feb; 749(2):340-3. PubMed ID: 9138735
[TBL] [Abstract][Full Text] [Related]
5. Evidence that D2 receptor-mediated activation of hypothalamic tuberoinfundibular dopaminergic neurons in the male rat occurs via inhibition of tonically active afferent dynorphinergic neurons.
Durham RA; Johnson JD; Moore KE; Lookingland KJ
Brain Res; 1996 Sep; 732(1-2):113-20. PubMed ID: 8891275
[TBL] [Abstract][Full Text] [Related]
6. Modification of morphine-induced locomotor activity by pertussis toxin: biochemical and behavioral studies in mice.
Funada M; Suzuki T; Narita M; Misawa M; Nagase H
Brain Res; 1993 Aug; 619(1-2):163-72. PubMed ID: 8374774
[TBL] [Abstract][Full Text] [Related]
7. Increased responsiveness of mesolimbic and mesostriatal dopamine neurons to cocaine following repeated administration of a selective kappa-opioid receptor agonist.
Heidbreder CA; Schenk S; Partridge B; Shippenberg TS
Synapse; 1998 Nov; 30(3):255-62. PubMed ID: 9776129
[TBL] [Abstract][Full Text] [Related]
8. Chronic treatment with naltrexone enhances morphine-stimulated dopamine neurotransmission: neurochemical and behavioral evidence.
Bardo MT; Neisewander JL; Ennis RB
Neuropharmacology; 1988 Nov; 27(11):1103-9. PubMed ID: 2849725
[TBL] [Abstract][Full Text] [Related]
9. Involvement of delta-opioid receptors in the effects of morphine on locomotor activity and the mesolimbic dopaminergic system in mice.
Narita M; Suzuki T; Funada M; Misawa M; Nagase H
Psychopharmacology (Berl); 1993; 111(4):423-6. PubMed ID: 7870983
[TBL] [Abstract][Full Text] [Related]
10. Blockade of the morphine-induced increase in turnover of dopamine on the mesolimbic dopaminergic system by kappa-opioid receptor activation in mice.
Narita M; Suzuki T; Funada M; Misawa M; Nagase H
Life Sci; 1993; 52(4):397-404. PubMed ID: 8380621
[TBL] [Abstract][Full Text] [Related]
11. Naloxone rapidly evokes endogenous kappa opioid receptor-mediated hyperalgesia in naïve mice pretreated briefly with GM1 ganglioside or in chronic morphine-dependent mice.
Crain SM; Shen KF
Brain Res; 2007 Sep; 1167():31-41. PubMed ID: 17692296
[TBL] [Abstract][Full Text] [Related]
12. Nor-Binaltorphimine Blocks the Adverse Effects of Morphine after Spinal Cord Injury.
Aceves M; Bancroft EA; Aceves AR; Hook MA
J Neurotrauma; 2017 Mar; 34(6):1164-1174. PubMed ID: 27736318
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological evidence for a motivational role of kappa-opioid systems in ethanol dependence.
Walker BM; Koob GF
Neuropsychopharmacology; 2008 Feb; 33(3):643-52. PubMed ID: 17473837
[TBL] [Abstract][Full Text] [Related]
14. Role of the kappa-opioid system in the attenuation of the morphine-induced place preference under chronic pain.
Suzuki T; Kishimoto Y; Misawa M; Nagase H; Takeda F
Life Sci; 1999; 64(1):PL1-7. PubMed ID: 10027746
[TBL] [Abstract][Full Text] [Related]
15. The kappa-opioid receptor antagonist, nor-binaltorphimine (nor-BNI), decreases morphine withdrawal and the consequent conditioned place aversion in rats.
Kelsey JE; Verhaak AM; Schierberl KC
Behav Brain Res; 2015 Apr; 283():16-21. PubMed ID: 25591478
[TBL] [Abstract][Full Text] [Related]
16. Further evidence for a peripheral component in the enhanced antinociceptive effect of systemic morphine in mononeuropathic rats: involvement of kappa-, but not delta-opioid receptors.
Catheline G; Kayser V; Guilbaud G
Eur J Pharmacol; 1996 Nov; 315(2):135-43. PubMed ID: 8960876
[TBL] [Abstract][Full Text] [Related]
17. Effects of opioid receptor antagonists on the effects of i.v. morphine on carrageenin evoked c-Fos expression in the superficial dorsal horn of the rat spinal cord.
Catheline G; Le Guen S; Besson JM
Brain Res; 1999 Apr; 824(1):105-11. PubMed ID: 10095048
[TBL] [Abstract][Full Text] [Related]
18. Nor-binaltorphimine precipitates withdrawal and excitatory amino acid release in the locus ceruleus of butorphanol--but not morphine-dependent rats.
Feng Y; Rockhold RW; Ho IK
J Pharmacol Exp Ther; 1997 Nov; 283(2):932-8. PubMed ID: 9353416
[TBL] [Abstract][Full Text] [Related]
19. Peripheral kappa-opioid receptors mediate the antinociceptive effect of fedotozine (correction of fetodozine) on the duodenal pain reflex inrat.
Diop L; Rivière PJ; Pascaud X; Junien JL
Eur J Pharmacol; 1994 Dec; 271(1):65-71. PubMed ID: 7698213
[TBL] [Abstract][Full Text] [Related]
20. Mu-opioid receptors are not involved in acute cocaine-induced locomotor activity nor in development of cocaine-induced behavioral sensitization in mice.
Lesscher HM; Hordijk M; Bondar NP; Alekseyenko OV; Burbach JP; van Ree JM; Gerrits MA
Neuropsychopharmacology; 2005 Feb; 30(2):278-85. PubMed ID: 15257307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
